Healthtech Startups

Carthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease. The company's technology uses low-intensity pulsed ultrasound combined with microbubbles to increase therapeutic efficacy of existing and new therapies.

3 investors

Cartogram provides indoor wayfinding and navigation software for hospitals, enabling patients to find their way to appointments and departments through turn-by-turn directions delivered via mobile app, SMS, and interactive kiosks. The platform integrates with hospital EMR systems and uses a proprietary indoor positioning system with BLE beacon technology for accurate navigation.

3 investors

Casana Care makes the Smart Seat, a toilet-mounted biometric monitoring device that tracks vital signs like heart rate, blood oxygen, and blood pressure trends for personal wellness tracking. The device is designed for everyday health monitoring in the home and shares data with family or doctors only at the user's discretion.

3 investors

Cascala develops clinical intelligence tools that combine medicine, engineering, product design, and AI to deliver relevant data at the point of care. The company operates in the healthcare technology space.

3 investors

CaseCtrl develops iQueue for Surgical Clinics, a digital surgical case management and scheduling platform for hospitals, ambulatory surgery centers, and private surgical practices. The platform integrates with EMR systems to replace paper-based workflows, optimize operating room allocation, reduce cancellations, and improve communication between surgeons, staff, patients, and insurance personnel.

3 investors

Casma is a biotech company developing technology that uses the autophagy pathway to degrade disease targets for therapeutic applications. The company combines molecular biology expertise with a proprietary discovery platform to identify and eliminate disease-causing cellular elements.

3 investors

Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions. Its tests serve healthcare providers and patients across multiple clinical focus areas to guide diagnosis, treatment, and follow-up care.

3 investors

Catalent is a global Contract Development and Manufacturing Organization (CDMO) that helps pharma, biotech, and self-care companies develop, manufacture, and deliver drug products and consumer health solutions. Its services span oral dose, biologics, specialty, and clinical supply, from early-stage design through commercial manufacturing.

3 investors

Cayuga Biotech is a clinical-stage biotechnology company developing therapeutics for hemorrhage and blood-clotting-related conditions, with a lead candidate CAY001. It focuses on the hemostasis and thrombosis space, drawing on materials chemistry and translational medicine.

3 investors

Cecelia Health provides virtual clinical care for people with cardiometabolic and chronic conditions, delivering coordinated, personalized care intended to reduce chronic care spend. It positions its service as a primary care visit rather than a supplemental "in-between" solution.

3 investors

Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities. The company applies this technology to stem cell transplantation and gene therapy for blood cancers such as leukemia and other blood and genetic diseases.

3 investors

Cellens develops a non-invasive, urine-based cancer diagnostics platform (Octosense) that uses nanoscale atomic-force imaging of single-cell biophysical markers combined with machine learning to detect cancer, with early data focused on bladder cancer detection. It applies mechanobiology and label-free cell analysis to cancer screening.

3 investors

Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine. Acquired by AbbVie Inc. in June 2024.

3 investors

CenExel operates a network of clinical research centers that conduct trials and studies to advance new medical treatments. The company serves pharmaceutical sponsors, biotech firms, and patients by providing clinical research infrastructure and expertise across 18 sites in the United States.

3 investors

Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.

3 investors

Lifepoint is a diversified healthcare delivery network operating community hospitals, rehabilitation and behavioral health hospitals, and additional sites of care across the healthcare continuum. Founded in 1999, it operates facilities across 34 U.S. states.

3 investors

Centese develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery that automates chest tube clog clearance and measures air leak rate and drainage volume, alerting care teams to disruptions. The system is aimed at clinicians and ICU/critical care teams to support post-operative patient monitoring and recovery.

3 investors

Cercle builds a platform that ingests and transforms healthcare data at scale into insights, with a focus on fertility and reproductive care. It serves healthcare and fertility businesses seeking to operate more efficiently and deliver more personalized care.

3 investors

Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.

3 investors

Chemomab is a clinical-stage biotech developing therapies that target the CCL24 cytokine involved in fibro-inflammatory diseases, with its lead antibody nebokitug tested in conditions including primary sclerosing cholangitis, systemic sclerosis, MASH and idiopathic pulmonary fibrosis. The company focuses on anti-fibrotic and anti-inflammatory treatments for patients with fibrotic diseases.

3 investors

Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.

3 investors

Chipiron develops a low-field MRI system using a patented cryogenic ultrasensitive detection system and AI-based noise cancellation and image reconstruction, aiming to acquire MRI signals in open environments without a Faraday cage. Its technology includes a breast-dedicated imaging sequence designed for clinically relevant scan times.

3 investors

Chirp provides privacy-preserving home monitoring solutions for seniors using voice-enabled sensors rather than wearables or cameras, allowing caregivers to remotely monitor and support older adults. The company serves family caregivers and senior living communities seeking dignified, non-intrusive monitoring technology.

3 investors

Chyral is an AI-powered photonics lab developing technology to read blood biochemistry non-invasively through the skin using light, machine learning, and models of light-tissue interaction.

3 investors